General Introduction

In 2000, in Prague, Czech Republic, the European Society of Oncology Pharmacy (ESOP) was established as a result of the actions undertaken by a group of European activists in oncology pharmacy who acknowledged the importance of continuous education, specialisation and knowledge exchange. Active contribution of oncology and hospital pharmacy professionals from 29 countries ensures the success of the society in achieving the initially stated aim of determining the optimal medical treatment for cancer patients, thereby improving the quality of their lives.

The European Journal of Oncology Pharmacy (EJOP) evolved from the electronic newsletter to its current print format with its first bi-annual issue published in January 2007. Starting from 2010, EJOP is published quarterly, and distributed to ESOP members. EJOP is accessible via www.ejop.eu.

Mission Statement/Editorial Objectives

• To provide information on professional topics to practising oncology pharmacists and technicians
• To offer a publishing platform to share professional achievements
• To disseminate information on recent scientific progress and give scientific overviews on oncology, particularly oncology pharmacy matters where the knowledge has moved forward significantly
• To provide diagnostic, therapeutic, chemical, pharmacological, toxicological and chemical background specifically related to oncology pharmacy
• To offer a regular communication channel to ESOP members and others quarterly
• To strengthen the profile of ESOP members’ professional status

Scope and Profile

The European Journal of Oncology Pharmacy (EJOP), published quarterly, sets out to offer a professional communication platform to European oncology pharmacy practitioners. As the official journal of the European Society of Oncology Pharmacy (ESOP), the scope of EJOP is to satisfy ESOP members’ needs in terms of improvement on professional standard, setting guidelines, further education and sharing practice experience. EJOP offers ESOP members an insight into the differences and commonalities of oncology pharmacy standards and training, as well as the opportunities to learn the unique benefits and advantages from the different oncology pharmacy practitioners.